Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | CA7 | P43166 | 3/20 | 0.58 |
| ▸ | CA9 | Q16790 | 3/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14107747 | 0.85 | LMNA (0.62) | ESR1LMNACYP1A2CYP3A4KMT2A | |
| SCHEMBL20160698 | 0.82 | CA1 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10256558 | 0.82 | CA1 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL87450 | 0.81 | CA1 (0.83) | CA12CA1CA2CA7CA9 | |
| Iodide SCHEMBL2890665 | 0.81 | CA1 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18312424 | 0.81 | ALDH1A1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14081917 | 0.80 | L3MBTL1 (0.46) | LMNAKMT2AALDH1A1L3MBTL1RAB9A | |
| SCHEMBL8927464 | 0.80 | TSHR (0.51) | ESR1LMNACYP3A4KMT2AALDH1A1 | |
| SCHEMBL4894958 | 0.80 | TP53 (0.51) | HPGD | |
| SCHEMBL10169860 | 0.79 | CA1 (0.56) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4364109-A | — | — | None | — | — | JP | disclosed |
| US-11056705-B2 | Organic anolyte materials for flow batteries | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2021-07-06 | — | — | US | disclosed |
| US-20180138539-A1 | ORGANIC ANOLYTE MATERIALS FOR FLOW BATTERIES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2018-05-17 | — | — | US | disclosed |
| US-20180138539-A1 | ORGANIC ANOLYTE MATERIALS FOR FLOW BATTERIES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2018-05-17 | — | — | US | disclosed |
| WO-2016200870-A1 | ORGANIC ANOLYTE MATERIALS FOR FLOW BATTERIES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-12-15 | — | — | WO | disclosed |
| US-7417156-B2 | Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers | JOHNS HOPKINS UNIVERSITY (US) | 2008-08-26 | — | — | US | disclosed |
| US-7417156-B2 | Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers | JOHNS HOPKINS UNIVERSITY (US) | 2008-08-26 | — | — | US | disclosed |
| EP-1270577-B1 | FUROISOQUINOLINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2006-12-06 | — | — | EP | disclosed |
| US-20060142377-A1 | Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high selectively, stability and efficacy and methods of making the same | JOHNS HOPKINS UNIVERSITY-LICENSE & TECHNOLOGY DEVE (US) | 2006-06-29 | — | — | US | disclosed |
| US-6924292-B2 | Furoisoquinoline derivatives, process for producing the same and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2005-08-02 | — | — | US | disclosed |
| US-20040092582-A1 | Furoisoquinoline derivatives, process for producing the same and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-05-13 | — | — | US | disclosed |
| WO-2004028476-A2 | ARTEMISININ-DERIVED TRIOXANE DIMERS | JOHNS HOPKINS UNIVERSITY (US) | 2004-04-08 | — | — | WO | disclosed |
| EP-1270577-A1 | FUROISOQUINOLINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-0576622-A1 | LITHOGRAPHIC PRINTING PLATES | EASTMAN KODAK COMPANY (US) | 1994-01-05 | — | — | EP | disclosed |
| JP-H04364109-A | HAIR TONIC | SHISEIDO CO LTD | 1992-12-16 | — | — | JP | disclosed |
| WO-1992017821-A1 | LITHOGRAPHIC PRINTING PLATES | EASTMAN KODAK COMPANY (US) | 1992-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092582-A1 | Furoisoquinoline derivatives, process for producing the same and use thereof | PDE3B, PDE5A, PDE3A | CA12 2215/4885CA1 832/4885CA2 186/4885 |
| US-20060142377-A1 | Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high selectively, stability and efficacy and methods of making the same | HCCS, ACIN1, ADH1A | CA12 184/4885CA1 24/4885CA2 91/4885 |
| US-20180138539-A1 | ORGANIC ANOLYTE MATERIALS FOR FLOW BATTERIES | NOX4, NDUFS4, CYBB | CA12 622/4885CA1 294/4885CA2 648/4885 |
| US-11056705-B2 | Organic anolyte materials for flow batteries | NOX4, NDUFS4, CYBB | CA12 622/4885CA1 294/4885CA2 648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.